Yilong Zheng

ORCID: 0000-0003-0899-4575
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Brain Metastases and Treatment
  • Meningioma and schwannoma management
  • Glioma Diagnosis and Treatment
  • Neurological disorders and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Pituitary Gland Disorders and Treatments
  • Genetic Neurodegenerative Diseases
  • Lung Cancer Research Studies
  • Spinal Hematomas and Complications
  • Botulinum Toxin and Related Neurological Disorders
  • Management of metastatic bone disease
  • Pain Management and Treatment
  • Transcranial Magnetic Stimulation Studies
  • Cerebrovascular and Carotid Artery Diseases
  • Polyomavirus and related diseases
  • Intracranial Aneurysms: Treatment and Complications
  • Vascular Malformations Diagnosis and Treatment
  • Teratomas and Epidermoid Cysts
  • Autophagy in Disease and Therapy
  • Neurosurgical Procedures and Complications
  • Trigeminal Neuralgia and Treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Adrenal and Paraganglionic Tumors
  • Acute Ischemic Stroke Management
  • Frailty in Older Adults

National University of Singapore
2021-2024

National University Hospital
2024

SingHealth
2024

Singapore General Hospital
2024

National Neuroscience Institute
2022

National University Health System
2021

Prior studies have shown that plaque inflammation on FDG-PET and the symptomatic carotid atheroma lumen-stenosis (SCAIL) score were associated with recurrent ischemic events, but findings thus far not been widely validated. Therefore, we aimed to validate of prior studies.A single-center prospective cohort study recruited patients (1) recent TIA or stroke within past 30 days, (2) ipsilateral artery stenosis ≥50%, (3) considered for early revascularization. The maximum standardized uptake...

10.3389/fneur.2023.1086465 article EN cc-by Frontiers in Neurology 2023-01-24

Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is a proven treatment modality for Parkinson’s disease (PD), reducing dyskinesia and time spent in the “OFF” state. This study evaluates long-term outcomes of STN-DBS PD patients up to 10 years post-surgery Singapore. Method: We conducted retrospective review Movement Disorders Society-Unified Disease Rating Scale (MDS-UPDRS) scores, activities daily living (ADLs), milestones, dopaminergic drug prescriptions, adverse events...

10.47102//annals-acadmedsg.2023374 article EN cc-by-nc-sa Annals of the Academy of Medicine Singapore 2024-08-20

Introduction: Subthalamic nucleus deep brain stimulation (STN-DBS) is a proven treatment modality for Parkinson’s disease (PD), reducing dyskinesia and time spent in the “OFF” state. This study evaluates long-term outcomes of STN-DBS PD patients up to 10 years post-surgery Singapore. Method: We conducted retrospective review Movement Disorders Society-Unified Disease Rating Scale (MDS-UPDRS) scores, activities daily living (ADLs), milestones, dopaminergic drug prescriptions, adverse events...

10.47102/annals-acadmedsg.2023374 article EN cc-by-nc-sa Annals of the Academy of Medicine Singapore 2024-08-20

10.1016/j.jocn.2023.08.004 article EN Journal of Clinical Neuroscience 2023-08-08

To identify the independent risk factors for 30-day perioperative seizures, as well to evaluate effect of seizures on overall mortality and tumor recurrence among patients who underwent surgical resection brain metastases.Patients metastases at our institution between 2011 2019 were included. defined presence any preoperative or postoperative diagnosed by a neurosurgeon neurologist within 30 days resection. Independent evaluated using multivariate logistic regression models. Kaplan-Meier...

10.3389/fonc.2022.1048304 article EN cc-by Frontiers in Oncology 2022-11-14

Structured abstract Objective To evaluate the association between primary tumour–brain metastasis receptor status mismatch and outcomes in patients with breast cancer brain (BCBM). Methods Patients who (1) had a histologically verified breast-to-brain metastasis, (2) were 18 years old or above on day of surgical resection, (3) ER (estrogen receptor), PR (progesterone HER2 (human epidermal growth factor 2) statuses both tumour secondary retrospectively recruited. Univariate time-to-event...

10.1101/2023.01.18.23284724 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2023-01-18
Coming Soon ...